Asymchem Net Receivables vs Selling General Administrative Analysis

002821 Stock

81.65 0.97 1.17%

Asymchem Laboratories financial indicator trend analysis is way more than just evaluating Asymchem Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Asymchem Laboratories is a good investment. Please check the relationship between Asymchem Laboratories Net Receivables and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asymchem Laboratories Tian. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Receivables vs Selling General Administrative

Net Receivables vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Asymchem Laboratories Net Receivables account and Selling General Administrative. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Asymchem Laboratories' Net Receivables and Selling General Administrative is 0.88. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Asymchem Laboratories Tian, assuming nothing else is changed. The correlation between historical values of Asymchem Laboratories' Net Receivables and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Asymchem Laboratories Tian are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Net Receivables i.e., Asymchem Laboratories' Net Receivables and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Receivables

Selling General Administrative

Most indicators from Asymchem Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Asymchem Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asymchem Laboratories Tian. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 514.9 M, whereas Tax Provision is forecasted to decline to about 163.4 M.

	2021	2022	2023	2024 (projected)
Operating Income	1.2B	3.2B	2.3B	2.4B
Total Revenue	4.6B	10.3B	7.8B	8.2B

Operating Income Total Revenue

Asymchem Laboratories fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Short Long Term Debt	Short Term Debt
Total Assets		0.5	0.97	1.0	0.79	0.97	0.82	0.99	0.96	-0.3	0.98	0.82	0.75	0.98	0.99	0.92	0.99	0.93	1.0	0.98	1.0	0.93	0.92	0.92	-0.3	-0.69
Other Current Liab	0.5		0.67	0.48	0.62	0.35	0.77	0.44	0.55	0.12	0.63	0.85	0.86	0.64	0.54	0.39	0.43	0.42	0.46	0.41	0.52	0.58	0.13	0.54	0.01	0.22
Total Current Liabilities	0.97	0.67		0.96	0.85	0.89	0.91	0.96	0.97	-0.2	0.98	0.92	0.89	1.0	0.96	0.86	0.93	0.84	0.95	0.91	0.97	0.92	0.82	0.92	-0.16	-0.51
Total Stockholder Equity	1.0	0.48	0.96		0.78	0.98	0.81	0.99	0.95	-0.31	0.98	0.81	0.74	0.97	0.98	0.93	0.99	0.93	1.0	0.99	1.0	0.92	0.93	0.92	-0.31	-0.7
Other Liab	0.79	0.62	0.85	0.78		0.72	0.95	0.77	0.88	-0.06	0.84	0.91	0.83	0.85	0.84	0.78	0.78	0.65	0.77	0.69	0.78	0.9	0.64	0.92	-0.26	-0.24
Retained Earnings	0.97	0.35	0.89	0.98	0.72		0.73	0.94	0.9	-0.34	0.94	0.71	0.6	0.91	0.96	0.95	0.99	0.97	0.98	0.98	0.96	0.89	0.94	0.88	-0.46	-0.78
Accounts Payable	0.82	0.77	0.91	0.81	0.95	0.73		0.79	0.9	-0.03	0.89	0.98	0.92	0.9	0.86	0.78	0.79	0.69	0.8	0.73	0.82	0.91	0.62	0.91	-0.24	-0.2
Cash	0.99	0.44	0.96	0.99	0.77	0.94	0.79		0.96	-0.3	0.95	0.79	0.75	0.97	0.96	0.88	0.97	0.87	0.99	0.97	0.99	0.89	0.94	0.9	-0.18	-0.71
Other Assets	0.96	0.55	0.97	0.95	0.88	0.9	0.9	0.96		-0.25	0.96	0.88	0.83	0.98	0.97	0.91	0.94	0.8	0.95	0.89	0.95	0.91	0.87	0.92	-0.23	-0.58
Long Term Debt	-0.3	0.12	-0.2	-0.31	-0.06	-0.34	-0.03	-0.3	-0.25		-0.24	-0.05	-0.01	-0.22	-0.27	-0.33	-0.33	-0.31	-0.31	-0.33	-0.29	-0.17	-0.39	-0.18	0.14	0.47
Net Receivables	0.98	0.63	0.98	0.98	0.84	0.94	0.89	0.95	0.96	-0.24		0.9	0.82	0.98	0.98	0.93	0.97	0.91	0.97	0.94	0.98	0.94	0.84	0.93	-0.33	-0.57
Inventory	0.82	0.85	0.92	0.81	0.91	0.71	0.98	0.79	0.88	-0.05	0.9		0.97	0.91	0.86	0.73	0.78	0.69	0.8	0.74	0.83	0.9	0.58	0.89	-0.13	-0.17
Other Current Assets	0.75	0.86	0.89	0.74	0.83	0.6	0.92	0.75	0.83	-0.01	0.82	0.97		0.87	0.79	0.6	0.68	0.57	0.72	0.66	0.78	0.81	0.51	0.8	0.09	-0.1
Total Liab	0.98	0.64	1.0	0.97	0.85	0.91	0.9	0.97	0.98	-0.22	0.98	0.91	0.87		0.97	0.88	0.95	0.86	0.96	0.93	0.98	0.93	0.84	0.93	-0.19	-0.55
Intangible Assets	0.99	0.54	0.96	0.98	0.84	0.96	0.86	0.96	0.97	-0.27	0.98	0.86	0.79	0.97		0.92	0.98	0.91	0.98	0.96	0.98	0.93	0.89	0.93	-0.34	-0.63
Common Stock	0.92	0.39	0.86	0.93	0.78	0.95	0.78	0.88	0.91	-0.33	0.93	0.73	0.6	0.88	0.92		0.95	0.88	0.92	0.89	0.9	0.86	0.88	0.85	-0.59	-0.69
Property Plant Equipment	0.99	0.43	0.93	0.99	0.78	0.99	0.79	0.97	0.94	-0.33	0.97	0.78	0.68	0.95	0.98	0.95		0.95	0.99	0.98	0.98	0.92	0.93	0.91	-0.39	-0.73
Short Term Investments	0.93	0.42	0.84	0.93	0.65	0.97	0.69	0.87	0.8	-0.31	0.91	0.69	0.57	0.86	0.91	0.88	0.95		0.94	0.96	0.92	0.87	0.84	0.84	-0.49	-0.7
Net Tangible Assets	1.0	0.46	0.95	1.0	0.77	0.98	0.8	0.99	0.95	-0.31	0.97	0.8	0.72	0.96	0.98	0.92	0.99	0.94		0.99	1.0	0.92	0.93	0.92	-0.31	-0.72
Other Stockholder Equity	0.98	0.41	0.91	0.99	0.69	0.98	0.73	0.97	0.89	-0.33	0.94	0.74	0.66	0.93	0.96	0.89	0.98	0.96	0.99		0.98	0.9	0.93	0.88	-0.31	-0.75
Total Current Assets	1.0	0.52	0.97	1.0	0.78	0.96	0.82	0.99	0.95	-0.29	0.98	0.83	0.78	0.98	0.98	0.9	0.98	0.92	1.0	0.98		0.92	0.91	0.92	-0.24	-0.67
Non Current Assets Total	0.93	0.58	0.92	0.92	0.9	0.89	0.91	0.89	0.91	-0.17	0.94	0.9	0.81	0.93	0.93	0.86	0.92	0.87	0.92	0.9	0.92		0.8	0.99	-0.3	-0.44
Non Currrent Assets Other	0.92	0.13	0.82	0.93	0.64	0.94	0.62	0.94	0.87	-0.39	0.84	0.58	0.51	0.84	0.89	0.88	0.93	0.84	0.93	0.93	0.91	0.8		0.81	-0.3	-0.87
Non Current Liabilities Total	0.92	0.54	0.92	0.92	0.92	0.88	0.91	0.9	0.92	-0.18	0.93	0.89	0.8	0.93	0.93	0.85	0.91	0.84	0.92	0.88	0.92	0.99	0.81		-0.27	-0.46
Short Long Term Debt	-0.3	0.01	-0.16	-0.31	-0.26	-0.46	-0.24	-0.18	-0.23	0.14	-0.33	-0.13	0.09	-0.19	-0.34	-0.59	-0.39	-0.49	-0.31	-0.31	-0.24	-0.3	-0.3	-0.27		0.35
Short Term Debt	-0.69	0.22	-0.51	-0.7	-0.24	-0.78	-0.2	-0.71	-0.58	0.47	-0.57	-0.17	-0.1	-0.55	-0.63	-0.69	-0.73	-0.7	-0.72	-0.75	-0.67	-0.44	-0.87	-0.46	0.35

Click cells to compare fundamentals

Asymchem Laboratories Account Relationship Matchups

Asymchem Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.8B	7.2B	15.2B	18.2B	19.8B	20.8B
Other Current Liab	161.8M	423.7M	1.1B	1.6B	191.9K	182.3K
Total Current Liabilities	504.0M	928.6M	2.2B	2.2B	1.8B	1.9B
Total Stockholder Equity	3.0B	6.0B	12.6B	15.6B	17.5B	18.4B
Other Liab	209.2M	238.4M	295.6M	257.3M	295.9M	158.3M
Retained Earnings	1.7B	2.3B	3.3B	6.2B	7.8B	8.1B
Accounts Payable	267.0M	378.6M	551.9M	568.9M	453.6M	270.7M
Cash	435.3M	2.1B	6.2B	5.3B	7.1B	7.5B
Other Assets	144.8M	287.6M	541.6M	415.0M	477.2M	501.1M
Net Receivables	712.4M	986.1M	1.8B	2.5B	2.0B	2.1B
Inventory	448.8M	726.4M	1.4B	1.5B	945.3M	557.6M
Other Current Assets	36.5M	189.6M	457.5M	376.4M	182.1M	119.0M
Total Liab	713.2M	1.2B	2.5B	2.5B	2.3B	2.4B
Intangible Assets	121.8M	285.7M	374.1M	473.2M	465.6M	488.9M
Common Stock	231.3M	242.5M	263.0M	369.9M	425.4M	446.7M
Property Plant Equipment	1.6B	2.5B	3.7B	5.4B	6.2B	6.5B
Net Tangible Assets	2.9B	5.9B	12.4B	15.4B	17.8B	18.6B
Other Stockholder Equity	7.7M	3.4B	9.1B	15.3B	17.6B	18.4B
Total Current Assets	1.6B	4.0B	10.3B	11.9B	12.4B	13.0B
Non Current Assets Total	2.1B	3.1B	4.8B	6.4B	7.4B	3.7B
Non Currrent Assets Other	54.1M	169.5M	354.7M	237.1M	688.5M	722.9M
Non Current Liabilities Total	209.2M	238.4M	341.5M	367.2M	456.4M	270.1M
Common Stock Shares Outstanding	231.4M	242.5M	263.1M	370.0M	369.7M	304.5M
Net Invested Capital	3.0B	6.0B	13.0B	15.6B	17.5B	9.4B
Net Working Capital	1.1B	3.1B	8.1B	9.7B	10.6B	5.5B
Capital Stock	231.3M	242.5M	263.0M	369.9M	369.5M	312.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Asymchem Stock

Balance Sheet is a snapshot of the financial position of Asymchem Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Asymchem Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Asymchem Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Asymchem currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Asymchem Net Receivables vs Selling General Administrative Analysis

Net Receivables vs Selling General Administrative

Net Receivables vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Net Receivables

Selling General Administrative

Asymchem Laboratories fundamental ratios Correlations

Asymchem Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Asymchem Laboratories fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Asymchem Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Short Term Debt	- 0.87	Non Currrent Assets Other
Short Term Debt	- 0.78	Retained Earnings
Short Term Debt	- 0.75	Other Stockholder Equity
Short Term Debt	- 0.73	Property Plant Equipment
Short Term Debt	- 0.72	Net Tangible Assets
Short Term Debt	- 0.71	Cash